
About this episode
As medical advances have helped extend lifespans, older people still experience a decline in quality of life in their later years as a result of diseases associated with aging. This can cause a loss of independence, isolation, and suffering. The Biogerontology Research Foundation, a United Kingdom-based nonprofit, is funding work to understand the molecular and cellular processes of aging and develop biotechnological interventions to halt or reverse damage from it. We spoke to Franco Cortese, deputy director of The Biogerontology Research Foundation, about a new report it’s issued that characterizes the longevity and geroscience landscape today, areas of research that hold promise, and why aging might best be thought of as a disease.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Bio Report

Resetting Severe Allergies at Their Cellular Source
The Bio Report
Sep 2, 202633:17pending

Innovating ADCs with Dual Targeting and Smarter Delivery
The Bio Report
Aug 26, 202629:35pending

Targeting the Brain’s Immune System in Alzheimer’s Disease
The Bio Report
Aug 19, 202634:19pending

How Gilead Is Building Durable Oncology and Immunology Franchises
The Bio Report
Aug 12, 202638:31pending